These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34436799)

  • 1. [(C C)Au(N N)]
    Khodjoyan S; Remadna E; Dossmann H; Lesage D; Gontard G; Forté J; Hoffmeister H; Basu U; Ott I; Spence P; Waller ZAE; Salmain M; Bertrand B
    Chemistry; 2021 Nov; 27(63):15773-15785. PubMed ID: 34436799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Hydrophilic Gold(I) N-Heterocyclic Carbene (NHC) Complexes as Potent TrxR Inhibitors Using Biochemical and Mass Spectrometric Approaches.
    Karaca Ö; Scalcon V; Meier-Menches SM; Bonsignore R; Brouwer JMJL; Tonolo F; Folda A; Rigobello MP; Kühn FE; Casini A
    Inorg Chem; 2017 Nov; 56(22):14237-14250. PubMed ID: 29095609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the C^N^C theme: Synthesis and biological properties of tridentate cyclometalated gold(III) complexes.
    Jürgens S; Scalcon V; Estrada-Ortiz N; Folda A; Tonolo F; Jandl C; Browne DL; Rigobello MP; Kühn FE; Casini A
    Bioorg Med Chem; 2017 Oct; 25(20):5452-5460. PubMed ID: 28823538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acridine-decorated cyclometallated gold(iii) complexes: synthesis and anti-tumour investigations.
    Williams MRM; Bertrand B; Fernandez-Cestau J; Waller ZAE; O'Connell MA; Searcey M; Bochmann M
    Dalton Trans; 2018 Oct; 47(38):13523-13534. PubMed ID: 30204186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and characterization of azolate gold(I) phosphane complexes as thioredoxin reductase inhibiting antitumor agents.
    Galassi R; Burini A; Ricci S; Pellei M; Rigobello MP; Citta A; Dolmella A; Gandin V; Marzano C
    Dalton Trans; 2012 May; 41(17):5307-18. PubMed ID: 22391922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterization, and antitumor activity of unusual pseudo five coordinate gold(III) complexes: distinct cytotoxic mechanism or expensive ligand delivery systems?
    Olsen PM; Ruiz C; Lussier D; Le BK; Angel N; Smith M; Hwang CB; Khatib R; Jenkins J; Adams K; Getcher J; Tham F; Chen ZG; Wilson EH; Eichler JF
    J Inorg Biochem; 2014 Dec; 141():121-131. PubMed ID: 25243390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic studies on two dinuclear organogold(III) compounds showing appreciable antiproliferative properties and a high redox stability.
    Gabbiani C; Casini A; Kelter G; Cocco F; Cinellu MA; Fiebig HH; Messori L
    Metallomics; 2011 Dec; 3(12):1318-23. PubMed ID: 21887452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemistry, structure, and biological roles of Au-NHC complexes as TrxR inhibitors.
    Karaaslan MG; Aktaş A; Gürses C; Gök Y; Ateş B
    Bioorg Chem; 2020 Jan; 95():103552. PubMed ID: 31911299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Variations on the Theme of Gold(III) C
    Carboni S; Zucca A; Stoccoro S; Maiore L; Arca M; Ortu F; Artner C; Keppler BK; Meier-Menches SM; Casini A; Cinellu MA
    Inorg Chem; 2018 Dec; 57(23):14852-14865. PubMed ID: 30457328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of apoptosis-inducing iminophosphorane organogold(III) complexes and study of their interactions with biomolecular targets.
    Shaik N; Martínez A; Augustin I; Giovinazzo H; Varela-Ramírez A; Sanaú M; Aguilera RJ; Contel M
    Inorg Chem; 2009 Feb; 48(4):1577-87. PubMed ID: 19146434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NHC gold halide complexes derived from 4,5-diarylimidazoles: synthesis, structural analysis, and pharmacological investigations as potential antitumor agents.
    Liu W; Bensdorf K; Proetto M; Abram U; Hagenbach A; Gust R
    J Med Chem; 2011 Dec; 54(24):8605-15. PubMed ID: 22091836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical biology of anticancer gold(III) and gold(I) complexes.
    Zou T; Lum CT; Lok CN; Zhang JJ; Che CM
    Chem Soc Rev; 2015 Dec; 44(24):8786-801. PubMed ID: 25868756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, characterization, and in vitro studies of bis[1,3-diethyl-4,5-diarylimidazol-2-ylidene]gold(I/III) complexes.
    Liu W; Bensdorf K; Proetto M; Hagenbach A; Abram U; Gust R
    J Med Chem; 2012 Apr; 55(8):3713-24. PubMed ID: 22424185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gold(I) NHC-based homo- and heterobimetallic complexes: synthesis, characterization and evaluation as potential anticancer agents.
    Bertrand B; Citta A; Franken IL; Picquet M; Folda A; Scalcon V; Rigobello MP; Le Gendre P; Casini A; Bodio E
    J Biol Inorg Chem; 2015 Sep; 20(6):1005-20. PubMed ID: 26202908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Gold(III) Pincer Ligand Scaffold for the Synthesis of Binuclear and Bioconjugated Complexes: Synthesis and Anticancer Potential.
    Bertrand B; O'Connell MA; Waller ZAE; Bochmann M
    Chemistry; 2018 Mar; 24(14):3613-3622. PubMed ID: 29334159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxicity of Pyrazine-Based Cyclometalated (C^N
    Bertrand B; Fernandez-Cestau J; Angulo J; Cominetti MMD; Waller ZAE; Searcey M; O'Connell MA; Bochmann M
    Inorg Chem; 2017 May; 56(10):5728-5740. PubMed ID: 28441013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gold(I) carbene complexes causing thioredoxin 1 and thioredoxin 2 oxidation as potential anticancer agents.
    Schuh E; Pflüger C; Citta A; Folda A; Rigobello MP; Bindoli A; Casini A; Mohr F
    J Med Chem; 2012 Jun; 55(11):5518-28. PubMed ID: 22621714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gold(i) and gold(iii) phosphine complexes: synthesis, anticancer activities towards 2D and 3D cancer models, and apoptosis inducing properties.
    Srinivasa Reddy T; Privér SH; Rao VV; Mirzadeh N; Bhargava SK
    Dalton Trans; 2018 Nov; 47(43):15312-15323. PubMed ID: 30187047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New cyclometalated gold (III) complex targeting thioredoxin reductase: exploring as cytotoxic agents and mechanistic insights.
    Abyar F; Tabrizi L
    Biometals; 2020 Jun; 33(2-3):107-122. PubMed ID: 32246384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiproliferative activity exerted by tricyclohexylphosphanegold(I) n-mercaptobenzoate against MCF-7 and A2780 cell lines: the role of p53 signaling pathways.
    Ang KP; Chan PF; Hamid RA
    Biometals; 2021 Feb; 34(1):141-160. PubMed ID: 33196940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.